Arcturus Therapeutics Holdings Inc (ARCT)
22.03
+0.26
(+1.19%)
USD |
NASDAQ |
Sep 27, 16:00
21.55
-0.48
(-2.18%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Net Income (Annual): -29.72M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -29.72M |
| December 31, 2022 | 9.349M |
| December 31, 2021 | -203.67M |
| December 31, 2020 | -72.15M |
| December 31, 2019 | -25.99M |
| December 31, 2018 | -21.78M |
| December 31, 2017 | -10.90M |
| Date | Value |
|---|---|
| December 31, 2016 | -1.571M |
| December 31, 2015 | -1.902M |
| December 31, 2014 | -32.83M |
| December 31, 2013 | -10.55M |
| December 31, 2012 | -1.579M |
| December 31, 2011 | -3.929M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-203.67M
Minimum
2021
9.349M
Maximum
2022
-64.44M
Average
-29.72M
Median
2023
Net Income (Annual) Benchmarks
| Fulcrum Therapeutics Inc | -97.34M |
| Bioventus Inc | -156.23M |
| Semler Scientific Inc | 20.58M |
| Liquidia Corp | -78.50M |
| AIM ImmunoTech Inc | -28.96M |